177 results
8-K
EX-3.1
vd1k co9r3mh5vzkon2q
17 Nov 22
Material Modifications to Rights of Security Holders
5:20pm
DEFA14A
l561goi1sf 0nvv
30 Sep 22
Additional proxy soliciting materials
4:18pm
8-K
EX-2.1
7uhfp pr9avgj841mwhn
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.4
vrp4w3wjg5ugurbqja4
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.5
kh116d47xy1xu
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
DEFA14A
EX-99.1
6p8b8neejq2eeeqo w8
28 Sep 22
Additional proxy soliciting materials
4:59pm
8-K
EX-99.1
dsi4dizu vg5c
28 Sep 22
Idera Pharmaceuticals Acquires Aceragen
4:29pm
8-K
EX-99.1
hbajsydiq de5hn59
17 May 22
Idera Pharmaceuticals Shares Positive Results from Investigator- Sponsored Trial in Melanoma Patients at Amsterdam UMC
10:14am